Z02: Publications

2018

  1. Baumann C, Schiele M, Herrmann MJ, Lonsdorf TB, Zwanzger P, Domschke K, Reif A, Deckert J, Pauli P (in press)
    Effects of an anxiety-specific psychometric factor on fear conditioning and fear generalization, Zeitschrift für Psychologie.
  2. Andreatta M, Neueder D, Genheimer H, Schiele MA, Schartner C, Deckert J, Domschke K, Reif A, Wieser MJ, Pauli P (in press)
    Human BDNF rs6265 polymorphism as a mediator for the generalization of contextual anxiety, J Neurosci Res.
  3. Angenendt J, Frommberger U, Domschke K (2018)
    Angststörungen, in: Psychische Erkrankungen:  Klinik und Therapie, Hrsg.: Berger M, Urban & Fischer, 6. Auflage; ISBN 978-3-437-22485-0.
  4. Domschke K, Hoyer J (2018)
    Angsterkrankungen (ICD-10 F4), in: Therapie psychischer Erkrankungen – State of the Art, Hrsg.: Voderholzer U, Hohagen F; Urban & Fischer, München, 12. Auflage, 2018; ISBN 978-3437249112.
  5. Schiele MA, Domschke K (2018)
    Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders, Genes Brain Behav, 17:e12423.
  6. Ströhle A, Gensichen J, Domschke K (2018)
    Angsterkrankungen, Dtsch Ärztebl Int, 155:611-620.
  7. Ziegler C, Domschke K (2018)
    Epigenetic signature of MAOA and MAOB genes in mental disorders, J Neural Transm, 125:1581-1588.
  8. Ziegler C, Schiele MA, Domschke K (2018)
    Patho- und Therapieepigenetik psychischer Erkrankungen, Nervenarzt, 89:1303-1314
  9. Schiele MA, Ziegler C, Kollert L, Katzorke A, Schwartner C, Busch Y, Gromer D, Pauli P, Deckert J, Herrmann MJ, Domschke K (2018)
    Plasticity of MAOA gene methylation: epigenetic correlate of treatment response in acrophobia, Int J Neuropsychopharmacology, 21:822-827.
  10. Hommers LG, Richter J, Yang Y, Raab A, Baumann C, Lang K, Schiele MA, Weber H, Wittmann A, Wolf C, Alpers GW, Arolt V, Domschke K, Fehm L, Fydrich T, Gerlach A, Gloster AT, Hamm AO, Helbig-Lang S, Kircher T, Lang T, Panné-Farré CA, Pauli P, Pfleiderer B, Reif A, Romanos M, Straube B, Ströhle A, Wittchen HU, Frantz S, Ertl G, Lohse MJ, Lueken U, Deckert J (2018)
    A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety, Transl Psychiatry, in Druck.
  11. Shiban Y, Brütting-Schick J, Pauli P, Domschke K, Mühlberger A (in press)
    Does caffeine facilitate exposure therapy in specific phobia? A randomized clinical trial, Resonanzen, in Druck.

2017

  1. Deckert J, Weber H, Villmann C, Lonsdorf TB, Richter J, Andreatta M, Arias-Vasquez A, Hommers L, Kent L, Schartner C, Cichon S, Wolf C, Schaefer N, von Collenberg CR, Wachter B, Blum R, Schuemann D, Scharfenort R, Schumacher J, Forstner A, Baumann C, Schiele MA, Notzon S, Zwanzger P, Janzing JGE, Galesloot T, Kiemeney LA, Gajewska A, Glotzbach-Schoon E, Mühlberger A, Alpers G, Fydrich T, Fehm L, Gerlach A, Kircher T, Lang T, Ströhle A, Arolt V, Wittchen U, Kalisch R, Büchel C, Hamm A, Noethen MM, Romanos M, Domschke K, Pauli P, Reif A (2017)
    GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: A potential neurogenetic pathway to panic disorder, Mol Psychiatry, 22:1431-9. 
  2. Lueken U, Kuhn M, Yang Y, Straube B, Kircher T, Wittchen HU, Pfleiderer B, Arolt V, Wittman A, Ströhle A, Weber H, Reif A, Domschke K, Deckert J, Lonsdorf TB (2017)
    Modulation of defensive reactivity by GLRB allelic variation: converging evidence from an intermediate phenotype approach, Transl Psychiatry, 7:e1227.
  3. Gottschalk MG, Domschke K (2017)
    Genetics of generalized anxiety disorder and related traits, Dialogues Clin Neurosci Vol 19, No 2.
  4. Schartner C, Ziegler C, Schiele M, Kollert L, Weber H, Zwanzger P, Arolt V, Pauli P, Reif A, Deckert J, Domschke K (2017)
    CRHR1 promoter hypomethylation: An epigenetic readout of panic disorder? Eur Neuropsychopharmacol, 27:360-371.
  5. Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain S, Cinosi E, Davies S, Domschke K,  Fineberg N, Grünblatt E, Jarema M, Kim YK, Maron E, Masdrakis V, Mikova O, Nutt D, Palanti S, Pini S, Ströhle A, Thibaut F, Vaghi M, Won E, Wedekind D, Wichniak A, Wooley J, Zwanzger P, Riederer P (2017)
    Biological Markers for Anxiety Disorders, OCD and PTSD – A Consensus Statement – Part II: Neurochemistry, Neurophysiology and Neurocognition, World J Biol Psychiatry, 18:162-214.

2016

  1. Schiele MA, Reinhard J, Reif A, Domschke K, Romanos M, Deckert J, Pauli P (2016) Developmental aspects of fear: Comparing the acquisition and generalization of conditioned fear in children and adults. Dev Psychobiol, 58:471-81.
  2. Gottschalk MG, Domschke K (2016)
    Novel developments in genetic and epigenetic mechanisms of anxiety. Curr Opin Psychiatry, 29:32-8.
  3. Bandelow B, Lueken U, Wolff J, Godemann F, Wolff-Mentzler C, Deckert J, Ströhle A, Beutel M, Wiltink J, Domschke K, Berger M (2016)
    Leitliniengerechte stationäre psychiatrisch-psychotherapeutische/psychosomatische Behandlung von Angststörungen: Wieviel Personal ist erforderlich? Nervenarzt, 87:302-10.
  4. Lueken U, Zierhut KC, Hahn T, Straube B, Kircher T, Reif A, Richter J, Hamm A, Wittchen U, Domschke K (2016)
    Neurobiological markers predicting treatment response in anxiety disorders: a systematic review and implications for clinical application, Neurosci Biobehav Rev, 66:143-62.
  5. Bandelow B, Baldwin D, Abelli M, Altamura C, Deckert J, Dell’Osso B, Domschke K, Fineberg N, Grünblatt E, Jarema M, Maron E, Nutt D, Pini S, Vaghi M, Wichniak A, Zai G, Riederer P (2016)
    Biological Markers for Anxiety Disorders, OCD and PTSD – A Consensus Statement – Part I: Neuroimaging and Genetics, World J Biol Psychiatry, 17:321-65.
  6. Schuebel K, Gitik M, Domschke K, Goldman D (2016)
    Making sense of epigenetics, Int J Neuropsychopharmacol, 19:1-10.
  7. Notzon S*, Domschke K*, Holitschke C, Ziegler C, Arolt V, Pauli P, Reif A, Deckert J, Zwanzger P (2016)
    Attachment style and oxytocin receptor gene variation interact in influencing social anxiety. World J Biol Psychiatry, 17:76-83  * shared first author.
  8. Hemmings SMJ, Martin LI, van der Merwe L, Benecke R, Domschke K, Seedat S (2016)
    Serotonin transporter variants play a role in anxiety sensitivity in South African adolescents. World J Biol Psychiatry, 17:66-75.
  9. Kuhn M, Scharfenort R, Schümann D, Schiele MA, Münsterkötter AL, Deckert J, Domschke K, Haaker J, Kalisch R, Pauli P, Reif A, Romanos M, Zwanzger P, Lonsdorf TB (2016)
    Mismatch or allostatic load? Timing of life-adversity differentially shapes gray matter volume and anxious-temperament. Soc Cogn Affect Neurosci, 11:537-47.
  10. Weber H, Richter J, Straube B, Lueken U, Domschke K, Schartner C, Klauke B, Baumann C, Pané-Farré C, Jacob CP, Scholz CJ, Zwanzger P, Lang T, Fehm L, Jansen A, Konrad C, Fydrich T, Wittman A, Pfleiderer B, Ströhle A, Gerlach AL, Alpers GW, Arolt V, Pauli P, Wittchen HU, Kent L, Hamm A, Kircher T, Deckert J, Reif A (2016)
    Allelic variation in CRHR1 predisposes to panic disorder: Evidence for biased fear processing. Mol Psychiatry, 21:813-22.
  11. Howe AS, Buttenschoen H, Bani-Fatemi A, Maron E, Otowa T, Erhardt A, Binder EB, Gregersen N, Mors O, Woldbye DP, Domschke K, Reif A, Shlik J, Koks S, Kawamura Y, Miyashita A, Kuwano R, Tokunaga K, Tanii H, Smoller J, Sasaki T, Koszycki D, De Luca V (2016)
    Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways. Mol Psychiatry, 21:665-79.
  12. Schiele MA, Ziegler C, Holitschke K, Schartner C, Schmidt B, Reif A, Romanos M, Pauli P, Zwanzger P, Deckert J, Domschke K (2016)
    Influence of 5-HTT variation, childhood trauma and self-efficacy on anxiety traits – a gene-environment-coping interaction study, J Neural Transm, 123:895-904.
  13. Prelog M, Hilligardt D, Schmidt CA, Przybylski GK, Leierer J, Almanzar G, El Hajj N, Lesch KP, Arolt V, Zwanzger P, Deckert J, Haaf T, Domschke K (2016)
    Hypermethylation of FOXP3 promoter and premature aging of the immune system in female patients with panic disorder? PloS ONE, 11:e0157930.

2015

  1. Domschke K, Winter B, Gajewska A, Unterecker S, Warrings B, Dlugos A, Notzon S, Nienhaus K, Gieselmann A, Herrmann MJ, Jacob C, Arolt V, Mühlberger A, Reif A, Pauli P, Deckert J, Zwanzger P (2015)
    Multilevel impact of the dopamine system on the emotion-potentiated startle reflex, Psychopharmacology 232:1983-1993.
  2. Hohoff C, Weber H, Richter J, Domschke K, Zwanzger PM, Ohrmann P, Bauer J, Suslow T, Kugel H,  Baumann C, Klauke B, Jacob CP, Fritze J, Bandelow B, Gloster AT, Gerlach AL, Kircher T, Lang T, Alpers GW, Ströhle A, Fehm L, Wittchen HU, Arolt V, Pauli P, Hamm A, Reif A, Deckert J (2015)
    RGS2 genetic variation: association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxiety. Am J Med Genet B Neuropsychiatr Genet 168B:211-222.
  3. Hommers L, Raab A, Bohl A, Weber H, Scholz CJ, Erhardt A, Binder E, Arolt V, Gerlach A, Gloster A, Kalisch R, Kircher T, Lonsdorf T, Ströhle A, Zwanzger P, Mattheisen M, Cichon S, Lesch KP, Domschke K, Reif A, Lohse MJ, Deckert J (2015)
    MicroRNA hsa-miR-4717-5p regulates RGS2 and may be a risk factor for anxiety-related traits. Am J Med Genet B Neuropsychiatr Genet 168B:296-306.
  4. Notzon S, Domschke K, Holitschke C, Ziegler C, Arolt V, Pauli P, Reif A, Deckert J, Zwanzger P (2015)
    Attachment style and oxytocin receptor gene variation interact in influencing social anxiety. World J Biol Psychiatry. DOI:10.3109/15622975.2015.1091502.
  5. Schiele MA, Reinhard J, Reif A, Domschke K, Romanos M, Deckert J, Pauli P (in press)
    Developmental aspects of fear: Comparing the acquisition and generalization of conditioned fear in children and adults. Developmental Psychobiology.
  6. Weber H, Richter J, Straube B, Lueken U, Domschke K, Schartner C, Klauke B, Baumann C, Pané-Farré C, Jacob CP, Scholz CJ, Zwanzger P, Lang T, Fehm L, Jansen A, Konrad C, Fydrich T, Wittman A, Pfleiderer B, Ströhle A, Gerlach AL, Alpers GW, Arolt V, Pauli P, Wittchen HU, Kent L, Hamm A, Kircher T, Deckert J, Reif A (2015)
    Allelic variation in CRHR1 predisposes to panic disorder by biasing towards fear. Mol Psychiatry. DOI:10.1038/mp.2015.125.
  7. Ziegler C, Dannlowski U, Braeuer D, Stevens S, Laeger I, Wittmann H, Tidow N, Mahr M, Kugel H, Heindel W, Dobel C, Hurlemann R, Reif A, Lesch KP, Arolt V, Gerlach A, Hoyer J, Deckert J, Zwanzger P, Domschke K (2015)
    Oxytocin receptor (OXTR) gene methylation – converging evidence for a role in social anxiety. Neuropsychopharmacology 40:1528-1538.
  8. Guhn A, Domschke K, Mueller LD, Dresler T, Eff F, Kopf J, Deckert J, Reif A, Herrmann MJ (2015) Neuropeptide S receptor gene variation and neural correlates of cognitive emotion regulation. Soc Cogn Affect Neurosci, 10:1730-7.
  9. Ruland T*, Domschke K*, Schütte V, Zavorotnyy M, Kugel H, Notzon S, Vennewald N, Ohrmann P, Arolt V, Pfleiderer B, Zwanzger P (2015)
    Neuropeptide S receptor gene variation modulates glutamatergic anterior cingulate cortex activity during CCK-4 induced panic. Eur Neuropsychopharmacol, 25:1677-82  *shared first author.
     

2014

  1. Klauke B, Deckert J, Zwanzger P, Baumann C, Arolt V, Pauli P, Reif A, Domschke K (2014)
    Neuropeptide S receptor gene (NPSR) and life events: G × E effects on anxiety sensitivity and its subdimensions. World J Biol Psychiatry 15:17-25.
  2. Mühlberger A, Andreatta M, Ewald H, Glotzbach-Schoon E, Tröger C, Baumann C, Reif A, Deckert J, Pauli P (2014)
    The BDNF Val66Met polymorphism modulates the generalization of cued fear responses to a novel context. Neuropsychopharmacology 5:1187-1195.
  3. Reif A, Richter J, Straube B, Höfler M, Lueken U, Gloster AT, Weber H, Domschke K, Fehm L, Ströhle A, Jansen A, Gerlach A, Pyka M, Reinhardt I, Konrad C, Wittmann G, Pfleiderer B, Alpers GW, Pauli P, Arolt V, Wittchen HU, Hamm A, Kircher T, Deckert J (2014)
    MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy. Mol Psychiatry 19:122-128.
  4. Domschke K (2014)
    Genetics of anxiety – theory and practice. J Neurol Neurochir Psychiatr, 15:90-5.
  5. Domschke K (2014)
    Prädiktive Faktoren bei Angststörungen. Nervenarzt, 85:1263-8.


2013

  1. Reif A, Richter J, Straube B, Höfler M, Gloster AT, Weber H, Domschke K, Fehm L, Ströhle A, Jansen A,  Lueken U, Gerlach A, Alpers GW, Pauli P, Arolt V, Wittchen HU, Hamm A, Kircher T, Deckert J (2013) MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy; in press at Molecular Psychiatry.
  2. Ernst LH, Lutz E, Fallgatter AJ, Reif A, Plichta MM (2013) Genetic variation in MAO-A modulates prefrontal cortical regulation of approach-avoidance reactions; in press at Neuropsychobiology.
  3. Baumann C, Klauke B, Weber H, Domschke K, Zwanzger P, Pauli P, Deckert J, Reif A (2013) The interaction of early life experiences with COMT val158met and MAOA affects endophenotypes of anxiety. Genes Brain Behav 12: 821-829.
  4. Domschke K (2013)
    Angsterkrankungen: Genetische Grundlagen. Neuroforum, 3:118-25.

2012

  1. Domschke K, Gajewska A, Winter B, Herrmann MJ, Mühlberger A, Wosnitza K, Glotzbach E, Conzelmann A, Dlugos A, Fobker M, Arolt V, Reif A, Pauli P, Zwanzger P, Deckert J  (2012) ADORA2A gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex; Neuropsychopharmacology 37: 759-769.
  2. Klauke B, Deckert J, Zwanzger P, Baumann C, Arolt V, Pauli P, Reif A, Domschke K (2012) Neuropeptide S receptor gene (NPSR) and life events: GxE effects on anxiety sensitivity and its subdimensions; in press at The World Journal of Biological Psychiatry.
  3. Kurrikoff T, Lesch KP, Kiive E, Konstabel K, Herterich S, Veidebaum T, Reif A, Harro J (2012) Association of a functional variant of NOS1 with personality, anxiety and depressiveness; Development and Psychopathology 24: 1225-1235.
  4. Conzelmann A, Reif A, Jacob CP, Weyers P, Lesch KP, Pauli P (2012) A polymorphism in the gene of the endocannabinoid degrading enzyme FAAH (FAAH C385A) is associated with emotional-motivational reactivity; Psychopharmacology 224: 573-579.
  5. Weber H, Scholz CJ, Domschke K, Baumann C, Klauke B, Jacob CP, Maier W, Fritze J, Bandelow B, Lang T, Fehm L, Ströhle A, Hamm A, Gerlach AL, Alpers GW, Kircher T, Wittchen HU, Arolt V, Pauli P,  Deckert J, Reif A (2012) Gender differences in associations of glutamate decarboxylase 1 gene (GAD1) variants with panic disorder; PLoS One 7(5):e37651.
  6. Reif A, Weber H, Domschke K, Klauke B, Baumann C, Jacob CP, Ströhle A, Gerlach A, Pyka M, Reinhard I, Konrad C, Wittmann A, Pfleiderer B, Alpers GW, Pauli P, Hamm A, Kircher T, Arolt , Wittchen HU,  Binder EB, Erhard A, Deckert J (2012) Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations; American Journal of Medical Genetics, Part B (Neuropsychiatric Genetics) 159B: 786-793.
  7. Domschke K, Klauke B, Winter B, Gajewska A, Herrmann MJ, Warrings B, Mühlberger A, Wosnitza K,  Dlugos A, Naunin S, Nienhaus K, Fobker M, Jacob CP, Arolt V, Pauli P, Reif A, Zwanzger P, Deckert J (2012) Modification of caffeine effects on the affect-modulated startle by neuropeptide S receptor gene variation; Psychopharmacology 222: 533-541.
  8. Erhardt A, Akula N, Schumacher J, Czamara D, Karbalai N, Müller-Myhsok B, Mors O, Kristensen AS,  Woldbye DPD, Koefoed P, Eriksson E, Maron E, Metspalu A, Nurnberger J, Philibert RA, Kennedy J,  Domschke K, Reif A, Deckert J, Otowa T, Kawamura Y, Kaiya H, Okazaki Y, Tanii H, Tokunaga L, Sasaki  T, Ioannidis JPA, McMahon FJ, Binder EB (2012) Replication and meta-analysis of TMEM132D gene variants in panic disorder; Translational Psychiatry 2:e156.
  9. Tupak SV, Reif A, Pauli P, Dresler T, Ehlis AC, Domschke K, Jochum C, Haas E, Baumann C, Weber H,  Herrmann MJ, Fallgatter AJ, Deckert J (2012) Neuropeptide S receptor gene: Fear-specific modulations of prefrontal activation; NeuroImage 66C: 353-360.
  10. Gajewska A, Blumenthal TD, Winter B, Herrmann MJ, Conzelmann A, Mühlberger A, Warrings B, Jacob CP, Arolt V, Reif A, Zwanzger P, Pauli P, Deckert J, Domschke K (2012) Effects of ADORA2A gene variation and caffeine on prepulse inhibition – a multi-level risk model of anxiety; Progress in Neuropsychopharmacology & Biologial Pyschiatry 40C: 115-121.

2011

  1. Raczka KA, Mechias ML, Gartmann N, Reif A, Deckert J, Pessiglione M,  Kalisch R (2011) Evidence for an involvement of the meso-striatal dopamine system in human fear extinction; Translational Psychiatry 1, e12, doi:10.1038/tp.2011.10.
  2. Klauke B, Deckert J, Reif A, Pauli P, Zwanzger P, Baumann C, Glöckner-Rist A, Domschke K (2011)Serotonin transporter gene and childhood trauma – a GxE effect on anxiety sensitivity; Depression and Anxiety 28: 1048-1057.
  3. Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Baumann C, Klauke B, Jacob CP, Maier W, Fritze J, Bandelow B, Krakowitzky P, Rothermundt M, Erhardt A, Binder E, Holsboer F,  Gerlach A,  Kircher T,  Lang T, Alpers G, Ströhle A,. Fehm L, Gloster A, Wittchen, U, Arolt V, Pauli P,  Hamm A, Deckert J (2011) Neuropeptide S (NPS) gene – converging evidence for a role in panic disorder. Molecular Psychiatry 16(9): 938-48.
  4. Lazary J, Juhasz G, Anderson I, Jacob CP, Nguyen TT, Lesch KP, Reif A, Deakin JFW,  Bagdy G (2011) Epistatic interaction of CREB1 and KCNJ6 on rumination and negative emotionality; European Neuropsychopharmacology 21(1): 63-70.
  5. Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S, Specht M, Kohli MA, Kloiber S, Ising M, Heck A, Pfister H, Zimmermann P, Lieb R, Puetz B, Uhr M, Weber P, Deussing JM, Gonic M, Bunck M, Keßler MS, Frank E, Hohoff C, Domschke K, Krakowitzky P, Maier W, Bandelow B, Jacob C, Deckert J, Schreiber S, Strohmaier J, Noethen M, Cichon S, Rietschel M, Bettecken T, Keck ME, Landgraf R, Müller-Myhsok B, Holsboer F, Binder EB (2011) TMEM132D a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry 16(6): 647-63.

2010

  1. Klauke B, Deckert J, Reif A, Pauli P, Domschke K (2010) Life events in panic disorder-an update on "candidate stressors".  Depress.Anxiety 27(8): 716-730.
  2. Raczka K, Gartmann N,  Mechias ML, Reif A, Büchel C, Deckert J, Kalisch R (2010) A neuropeptide S receptor variant that leads to over-interpretation of fear reactions: a potential neurogenetic basis for catastrophizing. Molecular Psychiatry 15(11):1045, 1067-74.
  3. Jacob C, Domschke K, Gajewska A, Warrings B, Deckert J (2010) Genetics of panic disorder - focus on association studies and therapeutic perspectives. in press at Expert Review of Neurotherapeutics 10(8): 1273-1284.
  4. Hahn T, Dresler T, Plichta MM, Ehlis AC, Ernst LH, Markulin F, Polak T, Blaimer M, Deckert J, Lesch KP, Jakob PM, Fallgatter AJ (2010) Functional Amygdala-Hippocampus Connectivity During Anticipation of Aversive Events is Associated with Gray's Trait "Sensitivity to Punishment". Biol Psychiatry. 68(5) 459-464.
  5. Domschke K, Dannlowski U, Hohoff C, Ohrmann P, Bauer J, Kugel H, Zwanzger P, Heindel W, Deckert J, Arolt V, Suslow T, Baune BT (2010) Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression. Eur Neuropsychopharmacol 20:301-30.
  6. Hohoff C, Mullings EL, Heatherley SV, Freitag C, Neumann L, Domschke K, Krakowitzky P, Rothermundt M, Keck ME, Erhardt A, Binder EB, Jacob C, Fritze J,  Bandelow B, Maier W, Holsboer F, Rogers PJ, Deckert J (2010)
    Adenosine A2A receptor gene: Evidence for association of risk variants with panic disorder and anxious personality. J Psychiatr Res 44(14):930-7.
  7. Pfleiderer B, Zinkirciran S, Michael N, Hohoff C, Kersting A, Arolt V, Heindel W, Deckert J, Domschke K (2010)Altered auditory processing in patients with panic disorder - a pilot study, World J Biol Psychiatry 11(8):945-55.
  8. Baffa A, Hohoff C, Baune BT, Müller-Tidow C, Tidow N, Freitag C, Zwanzger P, Deckert J, Arolt V, Domschke K (2010) Norepinephrine and serotonin transporter genes: Impact on treatment response in depression. Neuropsychobiology 62:121-131.

2009

  1. Domschke K, Dannlowski U, Hohoff C, Ohrmann P, Bauer J, Kugel H, Zwanzger P, Heindel W, Deckert J, Arolt V, Suslow T, Baune BT (2009)
    Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression. Eur Neuropsychopharmacol 20(5):301-309.